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Abstract Episomal vectors assembled from defined
genetic components are a promising alternative to
traditional gene therapy vectors that integrate in the
host genome and may cause insertional mutations.
The vector pEPI-eGFP is stably retained in the
episomal state in cultured mammalian cells at low
copy number for many generations without integra-
tion into the host genome. Although pEPI-eGFP is a
fully engineered vector, little is known about how it
interacts with the host genome and about the
molecular mechanisms that are responsible for its
transcriptional activity. We have analyzed the expres-
sion of the episomal reporter gene eGFP under
conditions that affect the chromatin state of the
genome. We have also constructed pEPI derivatives
carrying a tandem array of lac operator sequences,
which allows in vivo visualization and manipulation
of the chromatin state of the episome. We show that
changes in chromatin state of both the host and pEPI-
eGFP induces changes in episomal gene activity and
influences the episome’s nuclear distributions. We
conclude that episomal genes are subject to control
systems of the host, similarly to their counterparts in
the host genome.
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Introduction
The stable and safe transfer of genes to mammalian
and in particular human cells is of great interest for
biomedical and biotechnological research. A number
of transformation techniques have been developed
(reviewed in Conese et al. 2004; Glover et al. 2005;
Jackson et al. 2006; Van Craenenbroeck et al. 2000),
most of which employ vectors that assure stable
expression by integration in the host genome. However,
integration can disrupt host genes and position effects
make expression of the transgene unpredictable
(Hacein-Bey-Abina et al. 2003a; Hacein-Bey-Abina et
al. 2003b). As an alternative, non-integrating episomal
vectors have been developed. Such episomes are often
based on viral sequences (Conese et al. 2004;V a n
Craenenbroeck et al. 2000). They can be retained in the
episomal state in the host cell during cell division, may
have a stable level of gene expression and are assumed
not to be subject to position effects because of their non-
integrated state. However, since viral gene products can
be detrimental due to immunological complications or
undesired interactions with host cell components, their
use in humans is restricted (reviewed in Glover et al.
2005; Lipps et al. 2003).
Recently, a fully engineered non-viral episomal
vector (pEPI-eGFP) has been developed that may be a
safe alternative for gene transfer in mammals (Stehle
et al. 2007; Jenke et al. 2004b; Baiker et al. 2000;
Piechaczek et al. 1999). After transfection pEPI-eGFP
becomes a persistent episome in mammalian cells.
This property is attributed to the combination of a
2 kb S/MAR (scaffold/matrix attachment region)
sequence, which has been isolated from the human
β-interferon locus, and read-through transcription of a
gene into the S/MAR sequence (Jackson et al. 2006;
Jenke et al. 2004b; Stehle et al. 2003). Episomal
pEPI-eGFP is claimed to be present in cells at low
copy numbers, typically 2–10 per cell, based on
fluorescence in situ hybridization (FISH) labeling
(Baiker et al. 2000; Jenke et al. 2004b; Stehle et al.
2007). Interestingly, pEPI-eGFP not only remains
episomal in cultured cells, it was also found to persist
in various tissues of pig fetuses after sperm-mediated
transfer into the embryo, illustrating the robustness of
the S/MAR-based episomal system (Manzini et al.
2006). These properties make pEPI-eGFP a promising
vector for applications that aim at permanent genetic
transformation of mammals, including gene therapy
in man.
Despite the potential of the pEPI-GFP-type epi-
somes, we have only limited understanding of the
molecular mechanisms that ensure their extra-
chromosomal persistence and regulate expression of
their genes. Issues such as episomal replication,
faithful segregation during mitosis, and control of
transcription have hardly been addressed yet. It has
been shown that persistent pEPI-eGFP replicates once
per cell cycle in early S-phase (Schaarschmidt et al.
2004) and acquires a nucleosomal organization
enriched in marks for transcriptionally active chro-
matin, such as trimethylated histone H3K4 (Stehle et
al. 2007). Interestingly, these marks are particularly
enriched at the S/MAR sequence in pEPI-eGFP in a
cell-cycle-dependent manner (Rupprecht and Lipps
2009). Thus, although pEPI-eGFP is a stable extra-
chromosomal replicon, its chromatin state is at least in
part controlled by the host. For genes integrated in the
host genome it is well documented that the local
nuclear environment plays an important role in gene
expression, often by affecting the chromatin state
(Finlan et al. 2008, reviewed in Fraser and Bickmore
2007; Kumaran et al. 2008;Z h a oe ta l .2009).
Whether such processes also act in trans, affecting
episomes, is unknown.
To get insight into in trans-regulatory mechanisms
between host and episomal chromatin we have
combined in vivo 3D live cell microscopy with
molecular analysis of the episome by chromatin
immunoprecipitation (ChIP). Using the lac operator/
lac repressor (lacO/lacR) system (Robinett et al. 1996;
758 F. Tessadori et al.Verschure et al. 2005), we have visualized individual
episomes in living cells and manipulated their func-
tional state. Results show that transcriptional activation
is accompanied by a moderate relocation of the
episomes towards nuclear center. We provide evidence
that episomes can be transcriptionally activated by
changing the chromatin state of the host and likely also
of the episome, in particular by inhibiting DNA
methylation, decreasing histone H3K9 tri-methylation
and inhibiting histone deacetylation. We show that an
increase in acetylated episomal histone H3 is correlated
with enhanced episomal transcription. Taken together,
our data suggest that episomal genes behave remark-
ably similar to host genes.
Fig. 1 Plasmids used in this
study and episomal status.
a Map of pEPI-eGFP. b
Map of pELO64-eGFP. An
array of 64 lac operator sites
were cloned downstream
of the S/MAR sequence
of pEPI-eGFP. c Map of
pmCherry-lac repressor.
d Southern blot analysis
of DNA from CHO-K1 cells
carrying pEPI-eGFP and
pELO64 after restriction
with BamHI. The linearized
episomes pEPI-eGFP and
pELO64 are detected as a
single band at 6.7 kb (lane
1) and 9.2 kb (lane 2),
respectively. Lane L,
size ladder
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Vectors
Episomal vectors used were pEPI-eGFP (Baiker et al.
2000; Jenke et al. 2004b; Piechaczek et al. 1999) and
pELO64 (Fig. 1a, b). Plasmid pELO64 was con-
structed by restriction with BamHI/SalI of pEPI-eGFP
and insertion of a BamHI/SalI fragment containing
64 lac operator binding sites from plasmid pPs-8.8
( R o b i n e t te ta l .1996). For visualization of pELO64
in vivo, a plasmid expressing mCherry-lac repressor
b a s e do ne G F P - l a cr e p r e s s o r - A s c I - N L S( V e r s c h u r e
et al. 2005) was used after eGFP was replaced by
mCherry by BsrGI/AgeI cloning (Fig. 1c). Targeted
epigenetic manipulation of pELO64 was achieved
by using a plasmid expressing mCherry-lac
repressor-VP16 acidic activation domain. The
VP16 acidic activation domain was inserted into
the mCherry-lac repressor plasmid by EcoRV/MunI
cloning downstream of the lac repressor sequence
(Fig. 1c).
Cultured cells and transfection
Chinese Hamster Ovary (CHO-K1) cells were grown
in Ham’s F12 medium (Invitrogen, Carlsbad, CA,
USA) supplemented with 10% heat-inactivated fetal
bovine serum (FBS; Invitrogen), 100 units/ml peni-
cillin and 100 units/ml streptomycin (Invitrogen).
Suv39h1
-/- cells and immortalized mouse embryonic
fibroblasts (IMEFs) were grown as described else-
where (Peters et al. 2001). HCT116 cells were
cultured in McCoy’s 5A medium (Invitrogen) supple-
mented with 10% heat-inactivated FBS (Invitrogen),
100 units/ml penicillin and 100 units/ml streptomycin
(Invitrogen). All cells were cultured at 37°C with 5%
CO2. Transfection of all cells was carried out with
Lipofectamine 2000 (Invitrogen) according to the
manufacturer’s instructions. For the establishment of
cell lines that persistently carry the episomal vector,
24 h after transfection with the episomal construct,
CHO-K1, Suv39h1
−/− and IMEF cells were selected
on culture medium supplemented with respectively
500 μg/ml G418 (CHO-K1 cells) or 400 μg/mlG418
(Suv39h1
−/− and IMEF cells) for 3 weeks. The selected
cells were subsequently cultured with a 2-fold lower
concentration of G418 (Invitrogen). Transient transfec-
tion with mCherry-lac repressor for in vivo observa-
tions was carried out following the same protocol and
cells were analyzed 48 to 72 h after transfection.
DNA isolation and Southern blot analysis
Total genomic DNA was isolated from 10
6 CHO-
K1 cells and digested with the appropriate restriction
enzyme; 5 μg DNA of each sample were subse-
quently separated on 0.8% agarose gel and blotted
overnight to a nylon membrane (Fluka, Buchs SG,
Switzerland). A polymerase chain reaction (PCR)-
amplified 609-bp fragment, synthesized with the
primers 5′-GACGTAAACGGCCACAAGTT-3′ and
5′-GAACTCCAGCAGGACCATGT-3′ on the eGFP
sequence, was labeled with
32P and used as a probe.
Fluorescence in situ hybridization
FISH analysis was carried out essentially as described
elsewhere (Goetze et al. 2007). Prior to the RNAse
treatment a 5-min incubation in 0.1 mg/ml pepsin in
0.01 M HCl was added. pELO64 DNA was used as a
probe and labeled with either Biotin- or Digoxigenin-
Nick Translation kits (Roche, Mannheim, Germany).
Prior to microscopy samples were counterstained with
4′,6 ′-diamidino-2-phenylindole (DAPI; 1 μg/ml in
Vectashield, Vector Laboratories, Burlingame, CA,
USA).
Confocal scanning laser microscopy for in vivo
and FISH observation
Images were taken with a Zeiss LSM 510 (Zeiss,
Oberkochen, Germany) confocal laser scanning micro-
scope using a 63X Plan-A (1.4 NA) oil immersion
objective (Zeiss). For imaging eGFP, Alexa-488 and
fluorescein an argon 488-nm laser was used for
excitation. Emitted fluorescence was detected using a
505–530-nm band pass filter. For imaging mCherry a
568-nm krypton laser was used for excitation. Emitted
fluorescence was detected with a 585-nm-long pass
filter. For imaging DAPI-stained DNA, a 364-nm UV
laser was used. Emitted fluorescence was detected with
a3 8 5 –470-nm band pass filter.
In vivo microscopic observations
In vivo observations were carried out on a Zeiss
200 M (Zeiss) inverted fluorescence microscope
760 F. Tessadori et al.with a 20X Plan-N (0.75 NA) air objective (Zeiss).
For imaging green fluorescence (eGFP) a 490-nm
short-pass excitation filter was used. The emitted
fluorescence was detected by a 525–565-nm band
pass filter. Images were recorded with a cooled
CCD camera (Coolsnap HQ, Roper Scientific,
Tucson, AZ, USA).
Image analysis
Image analysis on confocal three-dimensional z-stacks
wascarriedoutusingArgossoftware(http://homepages.
cwi.nl/~wimc/argos). The Mann–Whitney U test for
two non-parametric, independent groups was carried
out using GraphPad Prism software (GraphPad Soft-
ware, San Diego, CA, USA). The integrated density of
individual mCherry-tagged episomal spots was mea-
sured on confocal 3D image stacks. For each spot the
intensity was measured in all relevant optical sections
(usually just one section), using ImageJ freeware
(http://rsb.info.nih.gov/ij/). Regions of interest (ROIs)
were defined containing the spot and values were
corrected for the intensity in ROIs of the same size in
the same section, not containing an episomal spot.
FACS analysis
Cells were trypsinized and resuspended in PBS-B (1×
BS; 0.5% (w/v) BSA). For fluorescence analysis, eGFP
and mCherry fluorescence were excited by lasers with
488- and 543-nm wavelengths, respectively. FACS
distributions were analyzed by segmentation of the
distribution of mCherry fluorescence intensity versus
eGFP fluorescence intensity. For quantification of
eGFP fluorescence, 2D distributions were segmented
as shown in Figs. 4b and 7b. Points in the lower right
section represented cells with above background eGFP
expression.
Trichostatin A and 5-aza-2′-deoxycytidine treatments
CHO-K1, IMEFs, and Suv39h1
−/− cells were grown
in medium supplemented with trichostatin A (TSA;
25, 50, and 100 ng/ml; Sigma, Zwijndrecht, The
Netherlands), 5-aza-2′-deoxycytidine (5, 25, and
50 μM; Fluka), or both drugs simultaneously. eGFP
fluorescence was evaluated microscopically or by
FACS analysis after 48, 72, and 96 h growth in the
presence of the drugs. For the two-tailed Student’s t
test (MS Excel, Microsoft, Redmond, WA, USA) was
used to identify statistical significance differences
(Fig. 6).
Chromatin immunoprecipitation
Chromatin immunoprecipitation was performed as
described previously (Hatzis et al. 2008). In brief,
CHO-K1/pEPI-eGFP cells were cross-linked with 1%
formaldehyde for 20 min. at room temperature. The
reaction was quenched with glycine at a final
concentration of 125 mM. The cells were subsequently
washed with phosphate-buffered saline, buffer B
(0.25% Triton-X 100, 10 mM ethylenediaminetetra-
acetic acid (EDTA), 0.5 mM ethylene glycol tetraacetic
acid (EGTA), 20 mM 4-(2-hydroxyethyl)-1-piperazi-
neethanesulfonic acid (HEPES; pH 7.6)), and buffer C
(0.15 M NaCl, 1 mM EDTA, 0.5 mM EGTA, and
20 mM HEPES (pH 7.6)) at 4°C for 10 min each. The
cells were then resuspended in ChIP incubation buffer
(0.3% sodium dodecyl sulfate (SDS), 1% Triton-X 100,
0.15MNaCl,1mMEDTA,0.5mMEGTA,and20mM
HEPES (pH 7.6)) and sheared using a Covaris S2
(Covaris,Woburn,MA,USA)sonicator for 10minwith
following settings: duty cycle, max; intensity, max;
cycles/burst, max. The final average size of chromatin
fragments was 500–1,000 bp. Sonicated chromatin was
incubatedfor 12h at4°C witha rabbit-raised polyclonal
anti-H3 antibody (ab 1791; Abcam plc, Cambridge,
UK)—this antibody recognizes both the non-acetylated
state as the acetylated form of histone H3—or a rabbit-
raised polyclonal anti-pan-acetyl-H3 (06-599, Upstate-
Millipore, Billerica, MA, USA) at a concentration of
2 μgo fa n t i b o d yp e r1 0
6 cells with protein G beads
(Upstate, Lake Placid, NY, USA). The beads were
successively washed two times with buffer 1 (0.1%
SDS, 0.1% deoxycholate, 1% Triton-X 100, 0.15 M
NaCl, 1 mM EDTA, 0.5 mM EGTA, and 20 mM
HEPES (pH 7.6)), one time with buffer 2 (0.1% SDS,
0.1% sodium deoxycholate, 1% Triton-X 100, 0.5 M
NaCl, 1 mM EDTA, 0.5 mM EGTA, 20 mM HEPES
(pH 7.6)), one time with buffer 3 (0.25 M LiCl, 0.5%
sodium deoxycholate, 0.5% NP-40, 1 mM EDTA,
0.5 mM EGTA, 20 mM HEPES (pH 7.6)), and two
times with buffer 4 (1 mM EDTA, 0.5 mM EGTA,
20 mM HEPES (pH 7.6)) for 5 min each at 4°C.
Precipitated chromatin was eluted by incubation of the
beads with elution buffer (1% SDS, 0.1 M NaHCO3)a t
room temperature for 20 min. After washing and
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linked by incubation at 65°C for 5 h in the presence of
200 mM NaCl, extracted with phenol-chloroform, and
ethanol precipitated.
Quantitative PCR
Quantitative PCR (qPCR) in an iCycler iQ Real-Time
PCR Detection System (BIORAD, Hercules, CA, USA),
using iQSYBR GreenSupermix (BIORAD),was carried
out for analysis of ChiP experiments. The manufacturer’s
recommendations were followed.The reactionvolume of
each qPCR reaction was 25 μlw i t haf i n a lc o n c e n t r a t i o n
of 0.8 μM for each primer. All primers used in this work
have been published previously in Stehle et al.
(2007) and Rupprecht and Lipps (2009)w i t ht h e
exception of primers for the Neo/Kan sequence on
pEPI-eGFP (5′-GATCTGGACGAAGAGCATCAG-3′
and 5′- GCCAACGCTATGTCCTGATAG-3′) and the
primers on intron 2 of the C. griseus Rhodopsin gene
(GenBank accession number: X61084.1; 5′-TAGGGA
CAGTGGTTTGGT-3′ and 5′-GGTGCGGCTTTTA
GAAACA-3′) used as endogenous control. ChIP
values are expressed as % of input. The results
were collected over a minimum of three technical
replicates.
Results
Experimental system
To allow in vivo visualization and manipulation of
pEPI-eGFP we constructed the modified episome
pELO64 (Fig. 1a), based on pEPI-eGFP (Baiker et
al. 2000; Piechaczek et al. 1999). pEPI-eGFP contains
the following functional elements: (1) a human S/
MAR sequence (isolated from the human INF-beta
gene), which is essential for episomal persistence, (2)
a selection marker conveying G418 resistance to
transfected cells, and (3) the reporter gene eGFP that
reads through into the S/MAR sequence. pELO64
(Fig. 1b) in addition carries a tandem array of 64
copies of the lac operator (lacO) sequence (2.5 kb) to
visualize the episome in vivo and to target chromatin
modifiers, using the lacO–lacR technology (Belmont
2001). Cell lines that persistently carry pELO64 or
pEPI-eGFP were made as described previously
(Baiker et al. 2000; Jenke et al. 2004b; Rupprecht
and Lipps 2009; Stehle et al. 2007). Three weeks after
transfection with the episome and culturing in
selection medium (500 μg/mlG418 for CHO-K1
cells), Southern analysis showed that pELO64 is
present as a single band (Fig. 1d; 9.2 kb), which is
the expected result for the episomal state (Piechaczek
et al. 1999; Stehle et al. 2003). Integration in the host
genome would result in multiple bands of different
sizes, as shown by others (Piechaczek et al. 1999;
Stehle et al. 2003; Jenke et al. 2004b). Removing the
selection pressure does not affect the persistence of
the episome in the host cells (Piechaczek et al. 1999;
data not shown). However, to ensure the presence of
pELO64 in all cells, the concentration of the selecting
agent G418 was kept at 250 μg/ml throughout all
experiments. Transient expression of the mCherry-lac
repressor fusion protein (mCherry-lacR; Fig. 1c;
Shaner et al. 2004) allows visualization of the
pELO64 episome in vivo and in fixed cells. The
mCherry-lacR gene is under control of a weak
polyoma promoter to avoid high background fluores-
cence of unbound protein.
Visualization of the pELO64 episome
in the interphase nucleus
To visualize pELO64 episomes in vivo, cells were
transiently transfected with a vector carrying the
mCherry-lacR fusion gene (Fig. 1c). Small
mCherry-labeled dots could be seen in nuclei of
transfected cells (Fig. 2a). Control cells that do not
contain pELO64 displayed no mCherry-labeled dots
(not shown), indicating that the dots represent
episomes. To underscore this conclusion, we carried
out FISH using the pELO64 sequence as a FISH
probe. Figure 2b shows that the mCherry-labeled
dots observed in vivo coincide with FISH-labeled
spots, further confirming that the mCherry-lacR
protein specifically labels pELO64. The average
number of dots per cell that contained at least one
detectable pELO64 was 1.8±1.3 (mean±SD; n=95).
Less than 15% of the cells contained more than two
pELO64 spots per nucleus. In about 25% of the
cells, no mCherry-tagged pELO64 was detectable
(Fig. 2c), probably due to the background fluores-
cence of unbound mCherry-lacR protein in the
nucleus. Using FISH, 2.5±0.9 (mean±SD; n=31)
pELO64 spots were detected in cells that contained
at least one recognizable FISH signal, very similar to
762 F. Tessadori et al.what is detected by in vivo labeling of pEPI with
mCherry-lacR (Fig. 2b). No FISH signal was
detected in about 9% of the observed cells. This
number of spots per cell is similar to what has been
found for pEPI-eGFP in previous studies (Nehlsen et
al. 2006; Piechaczek et al. 1999). FISH probably
results in overestimation of the number of episomal
spots per cell due to background noise whereas the
Fig. 2 In vivo visualization of the episome and quantification.
a Projection of z-stack of a confocal image of a nucleus of a
living CHO-K1 cell that persistently contains pELO64 and that
had been transiently transfected with a vector expressing
mCherry-lacR to visualize the episomes. Three mCherry-
labeled dots containing episomes are observed. b Visualization
of episomes by FISH and mCherry-lacR. The FISH signal for
pELO64 (green, top left) and mCherry-lacR signal (red, top
right) co-localize. The nucleus was counterstained with DAPI
(blue, bottom left). The bottom-right image is a merge of the
three other panels. To underscore the colocalization of the two
signals a rare cell containing 5 episomal spots was selected. c
Number of mCherry-labeled pELO64 dots per nucleus in CHO-
K1/pELO64 cells, measured 48 h after transient transfection
with mCherry-lacR (open bars) and with mCherry-lacR-VP16-
acidic domain (gray bars). d Distribution of the fluorescent
intensity per mCherry-tagged episomal spot in CHO-K1/
pELO64 nuclei, measured 48 h after transient transfection with
mCherry-lacR (open bars) and with mCherry-lacR-VP16-acidic
domain (gray bars). Scale bars=5 μm
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spots per cell probably is an underestimate due to the
background of unbound mCherry. Figure 2d (open
bars) shows the distribution of the integrated density
per nucleus of mCherry-labeled spots in CHO-K1
cells. The histogram shows a maximum at low
intensity values and over 60% of the integrated
intensities measured per cell are contained in the 3
lower bins of the histogram. The distribution is
skewed towards higher integrated intensities.
Our results on in vivo mCherry labeling and FISH
analysis in fixed cells show that the CHO-K1 cells
contain on average about two pELO64 episomes per
nucleus.
Expression of the episomal eGFP reporter gene
Figure 3 shows CHO-K1 cells that persistently carry
pELO64 episomes. Only 5% of the cells expresses the
episomal reporter gene eGFP at a detectable level,
showing a wide distribution of expression levels (FACS
data in Fig. 4b; control). Results in Fig. 1d (Southern
blot) make a loss of the eGFP gene due to recombina-
tion events unlikely. More so, many studies have
shown that the pEPI episome replicated synchro-
nously with the host genome and is faithfully
transferred to both daughter cells (Stehle et al.
2007; Jenke et al. 2004b; Schaarschmidt et al. 2004;
Baiker et al. 2000). Evidently, many cells carry
episomes that are in a state that allows only weak
gene expression, sufficient to obtain G418 resistance,
butnotsufficientforexpressionofeGFPatalevelthatis
detectable by fluorescence microscopy or FACS analy-
sis. Similar results have been reported for MEL cells
(Papapetrou et al. 2006). The expression of the
episomal Neo/Kan resistance gene may suppress eGFP
expression via promoter, a process called interference,
i.e., by inducing downstream changes in episomal
chromatin structure that hamper transcription of the
neighboring eGFP (Emerman and Temin 1984).
Fig. 3 Expression of the episomal reporter gene eGFP. eGFP-expressing cells in colonies of CHO-K1/pELO64 cells. Upper panels,
phase contrast; lower panels, eGFP. Scale bar in upper left panel,1 0μm
764 F. Tessadori et al.However, removal of the selection pressure did not
result in an increase in eGFP expression (data not
shown), making such interaction between the two
neighboring expression units unlikely.
Chromatin-modifying drugs affect episomal
expression levels
We have manipulated the chromatin state of the
episome and analyzed its effect on gene eGFP
expression. This was done in four different ways:
(1) increasing histone acetylation by inhibiting his-
tone deacetylase (HDAC) activity by culturing in the
presence of the HDAC inhibitor TSA, (2) decreasing
the DNA methylation level by inhibiting DNA methyl
transferase (DMT) activity by culturing cells in the
presence of 5-aza-2′-deoxycytidine, (3) decreasing
histone H3 lysine 9 tri-methylation (H3K9Me3) by
establishing episomes in IMEFs deficient for the
heterochromatic histone methyltransferase (HMT) Su
(Var)3–9, using the parent wild-type strain as a
control (Peters et al. 2001), and (4) targeting the
acidic activation domain of the viral transcriptional
activator VP16 to the lacO array on the episome
(Chuang et al. 2006; Tumbar and Belmont 2001). The
first three approaches affect episomal and host
chromatin alike, the fourth specifically targets the
episome.
CHO-K1/pELO64 cells were treated with the DMT
inhibitor 5-aza-2′-deoxycytidine (5-aza-dC; 48 h, 5
and 50 μM); (Jones 1985), with the HDAC inhibitor
TSA (48 h, 25 and 100 ng/ml); (Yoshida et al. 1990),
and with a combination of the two drugs. In these
experiments, we measured two aspects of eGFP
expression by FACS analysis: (1) the fraction of cells
that express eGFP (open bars), and (2) the average
expression per cell (filled bars, Fig. 4a). The
percentage of CHO-K1 cells that contain detectable
levels of eGFP is 5% in non-treated cultures (Fig. 4a;
control). Treatment with TSA or 5-aza-dC (25 and
100 ng/ml TSA; 5 and 50 μM 5-aza-dC, 48 h)
resulted in an up to 3.6- and a 3-fold increase in the
percentage of cells with detectable eGFP expression,
respectively(Fig.4a; 100 ng/ml TSA; 50 μM5 - a z a - d C ,
open bars). Simultaneous treatment with TSA and
5-aza-dC did not reveal synergy between the two drugs
(not shown). Figure 4b shows the FACS diagrams on
which the histogram is based. Clearly, there is a gradual
increase in expression, rather than an on-off type of
switching of the eGFP gene. In all cases there is no
detectable expression in a considerable fraction of cells.
These results indicate that the activity of genes on the
episome is directly or indirectly affected by a reduction
of histone deacetylase activity and of DNA methyla-
tion. In this sense the episomal gene behaves the same
as host genes.
Increased eGFP expression is accompanied
by an increased histone acetylation level
on the episome
To get insight into the changes in chromatin state of
the episome, we analyzed the histone H3 acetylation
level of the pEPI-eGFP episome in CHO-K1 cells by
ChIP before and after exposure to TSA (100 ng/ml,
48 h), followed by qPCR of co-precipitated episomal
DNA fragments. We analyzed various functional
elements of the episome (Rupprecht and Lipps 2009;
Schaarschmidt et al. 2004; Stehle et al. 2007)b y
immunoprecipitation with an antibody against the
core of histone H3 (Fig. 5a). The enrichment in
acetylation marks was analyzed with an antibody that
recognizes a variety of acetylated states of histone H3
(Fig. 5b). All functional elements of pEPI-eGFP that
were analyzed produced a clear histone H3-core signal,
confirming the chromatinized status of pEPI-eGFP
(Fig. 5a) .T r e a t m e n tw i t hT S Ar e s u l t e di nad e c r e a s e
of the qPCR signal for H3-core throughout the episome,
suggesting a loss in nucleosomal occupation of the
episome, ranging from a decrease of about 13.5% of the
qPCR signal for the HSV polyA sequence to close to
98% for the pCMV promoter driving the eGFP gene.
An alternative explanation is that histone H3 molecules
become less accessible for the antibody after TSA
treatment. This result shows that the increased transcrip-
tional activity of the episomal genes is correlated with a
loss or decrease in accessibility of nucleosomes, similar
to what is found for host genes (Li et al. 2007; Schones
et al. 2008). Nonetheless, consistent with the observed
episomal transcriptional activation, the qPCR signals for
H3Ac of most episomal sequences increased signifi-
cantly after TSA treatment, marking transcriptional
activation (Fig. 5b; Eberharter and Becker 2002).
PEPI-eGFP is thus responsive to modulation of
histone acetylation, in the same way as endogenous
sequences are.
S/MAR-based episomal genes are regulated at the chromatin level 765766 F. Tessadori et al.Episomal expression levels are controlled by various
chromatin-mediated mechanisms
In addition to CHO-K1 cells, we also analyzed
episomal expression in IMEFs that persistently carry
pEPI-eGFP. We used the fraction of cells that express
eGFP at a level that is detectable by light microscopy
as a measure of episomal activity. Basal expression
levels of pEPI-eGFP in IMEFs (Fig. 6a, control, all
Fig. 4 Chromatin manipulation in CHO-K1 cells. a Histogram
of FACS analyses of eGFP expression. Effect of TSA and 5-
aza-dC incubation (48 h treatment) on the expression of eGFP
in CHO-K1/pELO64 cells. The percentage of eGFP-expressing
cells (open bars) and the mean fluorescence intensity per cell
(gray bars, arbitrary units) are presented. b FACS data on
which histogram in (a) is based. Dots in the lower right region,
representing eGFP-expressing cells, are quantified in (a). For
each measurement at least 10
4 cells were analyzed. Control,
CHO-K1/pELO64 cells in standard culture medium

Fig. 5 ChIP analysis of pEPI-eGFP in CHO-K1 cells. a ChIP
with an antibody against histone H3-core carried out on CHO-
K1/ pEPI-eGFP cells cultured under standard conditions (open
bars) and after TSA treatment (100 ng/ml, 48 h, gray bars). b
ChIP with an antibody that recognizes various types of
acetylated histone H3 on CHOK1/pEPI-eGFP cells cultured
under standard conditions (open bars) and after TSA treatment
(100 ng/ml, 48 h, gray bars). Results were corrected for histone
H3-occupancy as described in (Haring et al. 2007). Error bars
correspond to the standard error of three replicates
S/MAR-based episomal genes are regulated at the chromatin level 767bars) were about 3-fold higher than observed for the
CHO-K1 cells (Fig. 4a, control, open bar). The mouse
cells were treated with the same chromatin-affecting
drugs as the CHO-K1 cells in Fig. 4. In untreated
IMEF cultures 18% of the cells showed eGFP
fluorescence (Fig. 6a, control). After 96 h of treatment
(Fig. 6a, black bars) this percentage increased to 99%
in cells treated with 50 ng/ml TSA (Fig. 6a; TSA
(50 ng/ml)) and to 49% after culturing in the presence
of 25 μM 5-aza-dC (Fig. 6a; 5-aza-dC (25 μM)).
Lower concentrations drugs and lower incubation times
resulted in smaller effects on eGFP expression (Fig. 6).
These results suggest that histone de-acetylation and
DNA methylation contribute significantly to silencing
of the episomal reporter gene. In the IMEF cells TSA-
mediated blocking of histone acetylation is sufficient
to induce eGFP expression in virtually all cells
(Fig. 6a). Under the same conditions only 20% of the
CHO-K1 cells become GFP-positive (Fig. 4a;T S A
(100 ng/ml), open bar). Evidently, one or more
unidentified inhibitory processes are (more) active in
CHO-K1 cells, compared with IMEFs.
To analyze the role of inhibition of episomal gene
expression by histone H3K9 methylation, the pEPI-
eGFP episome was established in mutant mouse
embryonic fibroblasts that do not express the enzyme
HMT Suv39h1 (Peters et al. 2001). Our choice was
motivated by the fact that, although Suv39h1 is
prominently known for its role in methylating H3K9
in constitutive heterochromatin (Lehnertz et al. 2003),
it has been shown that in IMEFs the activity of other
HMTs depend on the presence of Suv39h1 (Fritsch et
Fig. 6 Chromatin manipu-
lation in mouse embryonic
fibroblasts. Expression of
the episomal reporter gene
eGFP in wild-type IMEFs
(a) and Suv39h1
−/− mouse
embryonic fibroblasts (b)
in the presence of drugs
that affect chromatin. Bars
represent the percentage
of eGFP-expressing cells
48 h (open bars), 72 h
(light gray) and 96 h
(dark gray) after beginning
of drug treatment. Error
bars, average±standard
error of the mean. *p<0.05;
**p<0.01; ***p<0.001
significance value in
Suv39h1 deficient cells
compared with wild-type
IMEFs (two-tailed Student’s
t test)
768 F. Tessadori et al.al. 2010). This includes the HMTs G9a and GLP,
which are thought to be responsible for methylation of
H3K9 in euchromatin (Tachibana et al. 2005).
Choosing Suv39h1
−/− cells, which display a broad
spectrum of H3K9 methylation defects (Fritsch et al.
2010), was thus the most likely to affect the episomal
chromatin state. Indeed, these cells show an about 2-
fold higher basal eGFP expression (Fig. 6b) than their
parental wild-type cell line (Fig. 6a), suggesting that
H3K9 methylation plays a role in repressing episomal
gene expression in IMEFs. Increasing histone
acetylation by inhibiting HDAC activity with TSA
results in eGFP expression in close to 100% of the
Suv39h1
−/− cells after 96 h (Fig. 6b; TSA (25 ng/ml)
and TSA (50 ng/ml), dark gray bars), as was also
observed for wild-type cells (Fig. 6a, TSA (25 ng/ml)
and TSA (50 ng/ml), dark gray bars). Interestingly, the
transcriptional stimulation by inhibition of DNA
methyltransferase in the Suv39h1
−/− cells (Fig. 6b;5 -
aza-dC (5 μM) and 5-aza-dC (25 μM)) is considerably
stronger than in wild-type cells (Fig. 6a;5 - a z a - d C
(5 μM) and 5-aza-dC (25 μM)), irrespective of the
treatment duration (48-, 72-, or 96-h treatments)
r e s u l t i n gi ne G F Pe x p r e s s i o ni nu pt oa b o u t9 0 %o f
the cells after 96 h (Fig. 6b;5 - a z a - d C( 2 5μM), dark
gray bar). This underscores that, in addition to histone
H3K9 methylation and histone de-acetylation, DNA
methylation also contributes to silencing of the
episome and indicates that the episomal state of
pEPI-eGFP and its derivatives does not exempt them
from control by various cellular silencing processes.
Targeting of VP16 results in enhanced episomal gene
expression
To specifically manipulate the chromatin state of the
episome, we targeted the acidic activation domain of
the transcriptional activator protein VP16 to the
pELO64 episome in CHO-K1 cells, as a mCherry-
lacR-VP16-acidic activation domain fusion protein
(Fig. 1c). VP16 has been shown to enhance gene
activity among others via increasing histone acetyla-
tion (Tumbar et al. 1999). Indeed, 48 h after
transfection the percentage of eGFP expressing cells
had increased 9.2-fold (Fig. 7a), without a change in
the number of episomal spots per cell (Fig. 2c, gray
bars). The somewhat increased eGFP fluorescence per
spot (Fig. 2d, gray bars) compared with mCherry-
lacR-targeted episomes (Fig. 2d, open bars) may be
the result of enhanced accessibility of the lacO array
due to the chromatin-modifying properties of VP16.
The mean eGFP expression per cell increased 1.9-fold
(Fig. 7a). Figure 7b shows the FACS diagrams on
which the data in Fig. 7a are based. The expression of
mCherry-lacR-VP16 always was somewhat lower
than that of mCherry-lacR. Like the effect of TSA
(Fig. 4b), targeting VP16 does not simply switch on
the eGFP gene. Rather, cells with a wide range of
expression levels are observed.
Spatial distribution and mobility of the episome inside
the nucleus
Transcriptionally highly active and less active chro-
mosomes and sub-chromosomal domains have a
different radial distribution in interphase nuclei, the
former being on average closer to the nuclear center
than the latter (Cremer and Cremer 2001; Foster and
Bridger 2005; Goetze et al. 2007). To investigate
whether this also holds for pELO64 episomes, we
measured the 3D-radial nuclear position pn (pn=r0/rn)
of episomes, in which r0 is the distance between a
mCherry-labeled pELO64 episome spot and the
geometrical center of the nucleus, and rn the distance
between the center of the nucleus and the nuclear
envelope measured through the episomal spot (Goetze
et al. 2007). Figure 8 (open bars) shows that in a cell
population in which only about 5% expresses eGFP,
the radial distribution does not deviate significantly
from what is expected from a random radial distribu-
tion in a scalene ellipsoid with radii a, b, and c (a and
b being the equatorial radii and c the polar radius). The
ratio between the radii a=2b=3c approximates the
shape of CHO-K1 nuclei best. The distribution of the
episomes significantly changed after they were tran-
scriptionally activated by targeting mCherry-VP16-
lacR, relocating the episomes on average towards the
center of the nucleus (Fig. 8,g r a yb a r s ;p<0.01, non-
parametric Mann–Whitney U test). Except for the
radial distribution, no specific position of episomes
inside the nucleus was observed. Others have shown
that these episomes preferentially locate near early
replication sites in the nucleus (Stehle et al. 2007),
which are found in early S-phase throughout the
nucleus.
We have analyzed the mobility of the pELO64
episome in the G1 interphase nucleus of CHO cells
to establish whether these distributions are related
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shows a time series of images (z-stack projections)
over a period of 20 min, visualizing mCherry-tagged
pELO64 episomes inside the interphase nucleus of a
living CHO cell (full movie available as Electronic
supplementary material (Movie 1)). Any movement
that was observed was due to movement of (part
of) the nucleus, rather than to the episome inside
the nucleus. For instance, this is illustrated in Fig. 9
by the episome that moves due to an invagination of
the nuclear envelope (arrowhead). Four independent
experiments were done with the same result.
Evidently, pELO64 episomes show little or no
movement inside the interphase nucleus on a time
scale of tens of minutes, which agrees with observa-
tions on plasmids microinjected in mammalian cells
(Mearini et al. 2004).
Discussion
Artificial S/MAR-containing episomal vectors, such
as the pEPI-eGFP, have properties that make them
promising for stable and safe gene transfer, including
gene therapy, without integration into the host
genome (Baiker et al. 2000; Jackson et al. 2006;
Jenke et al. 2004b; Lufino et al. 2007; Manzini et al.
2006; Stehle et al. 2007). These episomes avoid the
risk of insertional mutagenesis and the uncertainty of
transgene expression due to position effects. Here we
focus on the regulation of expression of episomal genes
and chromatin state, using the pEPI-eGFP derived
pELO64 vector (carrying a 64 tandem array of LacO
sites) in two different mammalian cell lines as a model
system. Our main conclusion is that the regulatory
mechanisms that act on episomal genes seem to be
Fig. 7 Manipulation of
episomal chromatin in
CHO-K1 cells. a Episome-
specific chromatin modula-
tion by targeting of
mCherry-lacR-VP16-
acidic domain to pELO64
(48 h after VP16 transfec-
tion). The percentage of
eGFP-expressing cells
measured by FACS analysis
(open bars) and the mean
fluorescence intensity per
cell (gray bars,a r b i t r a r y
units) are presented. b FACS
data. Dots in the lower right
region, representing eGFP-
expressing cells, are quanti-
fied in (a). For all measure-
ments at least 10
4 cells were
analyzed. Control, CHO-K1/
pELO64 cells transfected
with mCherry-lacR in
standard culture medium.
mClacR refers to the
mCherry-lacR plasmid,
lacking VP16
770 F. Tessadori et al.similar to those that control host genes. In particular,
trans-acting mechanisms that affect chromatin by
changing histone modifications and DNA methylation
levels play a role in episomal gene regulation.
In cultures of CHO-K1 cells and IMEFs only a
fraction of the cells (5% to 24%, respectively) express
detectable levels of the episomal eGFP reporter gene
(Figs. 2, 3, 4, 5, and 6). Similar and higher values
(22% up to 60%) have been reported for other
mammalian host cell lines with pEPI episomes that
do not contain LacO repeats (Nehlsen et al. 2006;
Papapetrou et al. 2006), underscoring that pEPI
expression levels are cell-type dependent. This indi-
cates that the LacO array of the pELO episome has
little or no effect on the expression of the reporter
gene. Results discussed below suggest that cell-type-
dependent effects may in part depend on the balance
between different types of chromatin-affecting signals
in the cell. It has been suggested that the CMV
promoter sequence, which drives eGFP expression in
pEPI-eGFP, is prone to epigenetic silencing in rodent
cells (Brooks et al. 2004). However, when we
established pEPI-eGFP persistence in the human
colorectal carcinoma cell line HCT116, only 7% to
12% of the cells expressed eGFP to detectable levels
(data not shown), indicating that the low reporter gene
expression observed in CHO-K1 and IMEF cells is
not rodent-specific.
The low number of eGFP-expressing cells is remark-
able,since under G418selection pressureeachcellmust
containoneormoreepisomesthatexpresstheneomycin
resistance gene. It may be argued that non-expressing
cells lose the episome or the eGFP marker gene for
instance by recombination or during mitosis. However,
pEPI episomes have been shown to be persistent in
mammalian cells for many cell cycles and during
development (Stehle et al. 2007; Jenke et al. 2004b;
Schaarschmidt et al. 2004;B a i k e re ta l .2000;M a n z i n i
et al. 2006). Moreover, we grow the cells in the
presence of G418, which requires permanent presence
of the drug resistance gene. Finally, the observation that
after treatment with for instance TSA the fraction of
expressing cells increases from about 20% to 99%
shows that the marker gene is not lost, which is
consistent with the histone deacetylation-induced
silencing mechanism of pEPI-eGFP genes proposed by
Fig. 8 Transcriptional activation induces relocation of episomes
towards the nuclear center. The three-dimensional radial distribu-
tion of pELO64 in the interphase nucleus of CHO-K1 nuclei was
measured byconfocal microscopy. The nucleuswas subdivided in
ten concentric shells. Bars show the percentage of pELO64 dots
in each shell in cells 48 h after transfection with mCherry-lacR
(open bars, n=95) and 48 h after transfection with mCherry-
lacR-VP16-acidic domain (gray bars; n=41). The line shows
calculated values assuming a random radial distribution in a
scalene ellipsoid with radii a, b,a n dc (a and b being the
equatorial radii and c the polar radius). The ratio between the
radii is: a=2b=3c.The distribution of the mCherry-lacR and
mCherry-lacR-VP16 samples are significantly different (non-
parametric Mann–Whitney U test; p<0.01)
S/MAR-based episomal genes are regulated at the chromatin level 771(Papapetrou et al. 2006). Altogether, this makes it very
likely that the cells that do not express eGFP do carry
the episome in a silenced state.
Expression of the pEPI-eGFP reporter gene is
dependent on the chromatin state of the episome. It has
been shown that pEPI chromatin undergoes the same
modifications as host chromatin (Rupprecht and Lipps
2009; Stehle et al. 2007). Our results show that
inhibition of HDAC activity affects the episomal
chromatin by increasing the level of histone H3
acetylation similar to the host genome, i.e. it increases
histone acetylation and activates gene expression (Figs. 4
and 5). FACS analyses show that the global induction of
histone acetylation does not just switch on the eGFP
reporter gene. Rather, it increases the average expression
level, resulting in a wide range of expression levels
(Fig. 4b). Interestingly, different elements of the
episome are acetylated to a different extent after TSA
treatment. Particularly the pCMV promoter and the
polyA site become highly acetylated, probably directly
related to increased transcriptional activation of the
episome. In contrast to TSA and 5-aza-dC treatment,
targeting of the lacO-mCherry-VP16 acidic domain
chimeric protein to the lacO array is an episome-
specific way of gene activation (Fig. 7). The acidic
domain of VP16 is known to recruit histone acetyl-
transferase activity (Tumbar et al. 1999). FACS analysis
shows that, like the effect of TSA, VP16 targeting
increases the average expression level of the eGFP gene,
rather than just switching on the gene. The observed
activation of eGFP expression by VP16 is another
example showing that episomal genes behave similarly
to host genes.
Global changes in histone H3K9 methylation also
affect pEPI eGFP expression. Episomes in IMEF cells
that are deficient in H3K9 methyl transferase are
Fig. 9 Episomes are immobile in the nucleus at a time scale of
tens of minutes. Z-stack projections of nuclei of a living CHO-
K1/pELO64 cell acquired over a period of 20 min. The
arrowhead indicates one of the three mCherry-labeled pELO64
episomes, which follows the movement of its nuclear environ-
ment. Scale bar=5 μm
772 F. Tessadori et al.transcriptionally more active compared with the wild-
type cell line, implying that H3K9 methylation has an
inhibitory effect on episomal transcription (Fig. 6).
Similarly, experiments using the DNA methyltransferase
inhibitor 5-aza-dC show that DNA methylation sup-
presses episomal gene expression (Figs. 4 and 6). These
effects may be direct by changing episomal chromatin
orindirectviachanginghostproperties.Althoughlikely,
it is not certain that pEPI episomes undergo DNA
methylation and H3K9 methylation as literature on the
subject is either contradictory (Argyros et al. 2008;
Papapetrou et al. 2006; Jenke et al. 2004a)o rl a c k s
detail (Stehle et al. 2007). Interestingly, if mutant
mouse cells that lack H3K9 methyltransferase were
exposed to 5-aza-dC, their eGFP expression levels
increased significantly more than after a similar
treatment of wild-type IMEFs (Fig. 6), indicating
synergy between the H3K9 methylation and DNA
methylation systems (Fuks 2005).
We present microscopic evidence that cells stably
contain between 1 and 3 spots that contain one or more
episome molecules per interphase nucleus (Fig. 2).
Earlier studies found similar numbers based on FISH
labeling (Baiker et al. 2000; Nehlsen et al. 2006;S t e h l e
et al. 2007). Our results confirm those studies using
FISH on fixed cells and in vivo mCherry labeling, using
the lacO/lacR method (Fig. 2; Belmont 2001). Remark-
ably, episomes are not motile at a time scale of tens of
minutes and do not show a corralled type of local low
amplitude movement, suggesting that they are firmly
bound to host chromatin or other nuclear structures
(Fig. 9 and Electronic supplementary material (Movie
1)). Evidence has been presented that episomes prefer-
entially interact with early replication sites (Stehle et al.
2007), which are distributed throughout the nucleo-
plasm. This may be related to the finding that pEPI
episomes are often attached to metaphase chromosomes
in metaphase spreads (Baiker et al. 2000; Jenke et al.
2004b; Nehlsen et al. 2006; Stehle et al. 2007).
Alternatively, immobilization could be due to binding
to nucleoskeletal structures via the S/MAR sequence
(Jenke et al. 2002). Despite this immobility, episome
seem to reallocate to positions closer to the nuclear
center if their gene expression is up-regulated by the
targeting of mCherry-lacR-VP16 acidic domain
(Fig. 8). This is similar to what is observed for
genomic loci, i.e., transcriptionally highly active
chromosomes and sub-chromosomal domains are
located closer to the nuclear center than genomic areas
that are less active (Cremer and Cremer 2001;G o e t z e
et al. 2007; Lanctot et al. 2007).
In summary, our results seem to indicate that
regulatory mechanisms affect episomal genes in a
similar manner as host genes. This indicates that for
application in gene therapy-specific epigenetic control
elements must be incorporated in pEPI-like episomal
vectors to assure reliable gene expression in a wide
range of cell types and physiological conditions.
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